Cogent Biosciences Inc.

(NASDAQ:COGT) Trade

Symbol has changed to a new ticker symbol

(FLNT)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

Contact Information

Website: www.cogentbio.com
Email: stephanie@sternir.com
Main Phone: +1 617 945-5576
Address: 200 Cambridge Park Drive
Address 2: Suite 2500
State: MA
City / Town: Cambridge
Country: US
Postal Code: 02140

Issuer Information

Exchange: NGS
CEO: Andrews R. Robbins
Employees: 15
Issuer Type: CS - Common Stock
Sector/Industry: Technology
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A